Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone
1997

Effects of Estrogen and Progesterone on IGF Receptor in Breast Tissue

publication Evidence: moderate

Author Information

Author(s): RB Clarke, A Howell, E Anderson

Primary Institution: Christie Hospital NHS Trust

Hypothesis

Does estrogen treatment increase IGF receptor expression in normal human breast tissue?

Conclusion

Estrogen treatment significantly increases IGF receptor mRNA levels in normal breast tissue, while progesterone treatment decreases them.

Supporting Evidence

  • Estrogen treatment increased IGF receptor mRNA levels by 250% after 7 days.
  • Progesterone treatment decreased IGF receptor mRNA levels to 30% of untreated levels.
  • Combination treatment of estrogen and progesterone resulted in a twofold increase in IGF receptor mRNA.

Takeaway

When normal breast tissue is treated with estrogen, it makes more IGF receptors, which help cells grow. But when treated with progesterone, it makes fewer receptors.

Methodology

The study used quantitative reverse transcription - polymerase chain reaction (RT-PCR) to analyze IGF receptor mRNA levels in breast xenografts treated with estrogen and progesterone.

Limitations

The study did not quantify changes in cell surface IGF receptor concentrations.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication